用免疫吸附治疗治疗严重和/或不耐药的型皮虫的辅助疗法 - 一个潜在的单中心试点研究
Maike M Holtsche1,2, Nina van Beek1, Christoph M Hammers1
1Department of Dermatology, University of Lübeck, Lübeck, Germany.
概括
免疫吸附 (IA) 是一种安全有效的治疗方法,可以治疗严重的血栓性皮虫 (BP). 这种疗法显著降低了自身抗体,并且在耐药血压患者中实现了高缓解率.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 球状皮虫 (BP) 是一种普遍存在的自身免疫性水泡性疾病.
- 皮质类固醇是标准治疗,但耐火病例需要替代疗法.
- 指导方针建议在严重或耐火性血压时进行免疫吸附 (IA).
研究的目的:
- 评估IA的安全性和有效性,作为严重/耐药血压的辅助疗法.
- 评估IA对抗BP180IgG抗体水平的影响.
- 在血压患者中记录IA治疗相关的不良事件.
主要方法:
- 十名患有严重/耐药血压的患者在连续三天内接受IA (LigaSorb®) 治疗.
- 同时治疗包括口服的普雷迪尼索隆,达普森和局部的莫梅松酸.
- 在12个月的随访期间,对患者的结果和不良事件进行了监测.
主要成果:
- 50%的患者在2个月后完全缓解,90%的患者在IA后6个月后完全缓解.
- 血清抗BP180IgG水平显著下降,平均在IA后立即降低89%,并在4周后降低73%.
- 记录了56个不良事件;50%是2级,15个是严重的 (3-4级).
结论:
- 艾亚是一种相对安全和有效的辅助疗法,用于严重或不耐药的类皮虫.
- 艾亚在实现缓解和减少BP中的自身抗体方面表现出显著的有效性.
- 虽然不良事件发生,但IA为难以治疗的高血压病例提供了可行的治疗选择.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
475
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
475
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
423
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
423
01:29Inflammatory Bowel Disease IV: Pharmacological Management
463
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
463